These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38970125)

  • 1. Applying the WHO-INTEGRATE evidence-to-decision framework in the development of WHO guidelines on parenting interventions: step-by-step process and lessons learnt.
    Movsisyan A; Backhaus S; Butchart A; Gardner F; Strahwald B; Rehfuess E
    Health Res Policy Syst; 2024 Jul; 22(1):79. PubMed ID: 38970125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing the WHO-INTEGRATE Framework as a Tool for Evidence-Informed, Deliberative Decision-Making Processes: Exploring the Views of Developers and Users of WHO Guidelines.
    Stratil JM; Paudel D; Setty KE; Menezes de Rezende CE; Monroe AA; Osuret J; Scheel IB; Wildner M; Rehfuess EA
    Int J Health Policy Manag; 2022 May; 11(5):629-641. PubMed ID: 33131223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the WHO-INTEGRATE evidence-to-decision framework to develop recommendations for induction of labour.
    Murano M; Chou D; Costa ML; Turner T
    Health Res Policy Syst; 2022 Nov; 20(1):125. PubMed ID: 36344986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspective.
    Rehfuess EA; Stratil JM; Scheel IB; Portela A; Norris SL; Baltussen R
    BMJ Glob Health; 2019; 4(Suppl 1):e000844. PubMed ID: 30775012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Going into the black box": a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations.
    Ingold H; Gomez GB; Stuckler D; Vassall A; Gafos M
    Front Public Health; 2024; 12():1292475. PubMed ID: 38584925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19.
    Stratil JM; Voss M; Arnold L
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33234529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 3 - Using qualitative evidence syntheses to develop implementation considerations and inform implementation processes.
    Glenton C; Lewin S; Lawrie TA; Barreix M; Downe S; Finlayson KW; Tamrat T; Rosenbaum S; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):74. PubMed ID: 31391071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.
    Stratil JM; Baltussen R; Scheel I; Nacken A; Rehfuess EA
    Cost Eff Resour Alloc; 2020; 18():8. PubMed ID: 32071560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid development of an evidence- and consensus-based guideline for controlling transmission of SARS-CoV-2 in schools during a public health emergency - A process evaluation.
    Wabnitz K; Rueb M; Pfadenhauer LM; Strahwald B; Rehfuess EA
    Front Public Health; 2023; 11():1075210. PubMed ID: 37064706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 - Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements.
    Downe S; Finlayson KW; Lawrie TA; Lewin SA; Glenton C; Rosenbaum S; Barreix M; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):76. PubMed ID: 31391057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When complexity matters: a step-by-step guide to incorporating a complexity perspective in guideline development for public health and health system interventions.
    Movsisyan A; Rehfuess E; Norris SL
    BMC Med Res Methodol; 2020 Oct; 20(1):245. PubMed ID: 33008285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 2 - Using qualitative evidence synthesis findings to inform evidence-to-decision frameworks and recommendations.
    Lewin S; Glenton C; Lawrie TA; Downe S; Finlayson KW; Rosenbaum S; Barreix M; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):75. PubMed ID: 31391119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.
    Moberg J; Oxman AD; Rosenbaum S; Schünemann HJ; Guyatt G; Flottorp S; Glenton C; Lewin S; Morelli A; Rada G; Alonso-Coello P;
    Health Res Policy Syst; 2018 May; 16(1):45. PubMed ID: 29843743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaching beyond the review of research evidence: a qualitative study of decision making during the development of clinical practice guidelines for disease prevention in healthcare.
    Richter Sundberg L; Garvare R; Nyström ME
    BMC Health Serv Res; 2017 May; 17(1):344. PubMed ID: 28490325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update.
    Skivington K; Matthews L; Simpson SA; Craig P; Baird J; Blazeby JM; Boyd KA; Craig N; French DP; McIntosh E; Petticrew M; Rycroft-Malone J; White M; Moore L
    Health Technol Assess; 2021 Sep; 25(57):1-132. PubMed ID: 34590577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.